Access anti-HBc Total

FDA 510(k) K253687 · Beckman Coulter, Inc.

Substantially Equivalent

510(k) numberK253687

Submission

Device name
Access anti-HBc Total
Applicant
Beckman Coulter, Inc.
Chaska, MN, US
Received
November 21, 2025
Decision date
February 19, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
SEI – Qualitative And Quantitative Hepatitis B Virus Antibody Assays
Device class
Class II (moderate risk)
Regulation
21 CFR 866.3173
Specialty
Microbiology

In vitro diagnostic devices intended for use in the detection of antibodies to HBV. These devices are intended to aid in the diagnosis of HBV infection in persons with signs and symptoms of hepatitis and in persons at risk for HBV infection. Anti-HBs assay results may be used as an aid in the determination of susceptibility to HBV infection in individuals prior to or following HBV vaccination or…

Other 510(k)s with product code SEI

510(k)DeviceApplicantDecision
K260049Elecsys Anti-HBc IgMSEI · Traditional Roche Diagnostics04/07/2026SE
K260046Elecsys Anti-HBc IISEI · Traditional Roche Diagnostics04/07/2026SE
K254059Access anti-HBc IgMSEI · Traditional Beckman Coulter, Inc.03/13/2026SE

More from Beckman Coulter, Inc.

510(k)DeviceDecision
K252169Access BNP IINBC · Traditional 03/24/2026SE
K254059Access anti-HBc IgMSEI · Traditional 03/13/2026SE
K251995Access anti-HAV IgMLOL · Traditional 01/27/2026SE
K250588Access Rubella IgGLFX · Traditional 11/17/2025SE
K252580iQ200 SeriesLKM · Special 09/10/2025SE
K243846Access anti-HAVLOL · Traditional 09/09/2025SE
K243804MicroScan Dried Gram-Negative MIC/Combo Panels with Cefepime (CPE) (0.12-64 µg/mL)…LTT · Traditional 08/20/2025SE
K250036MicroScan Dried Gram-Positive MIC/Combo Panels with Daptomycin (DAP) (0.06-32 µg/mL)LTT · Traditional 08/15/2025SE
K243483Access hsTnIMMI · Traditional 08/01/2025SE
K250084MicroScan Dried Gram-Negative MIC/Combo Panels with Aztreonam (AZT) (0.5-64 µg/mL)LTT · Traditional 07/18/2025SE

Questions and answers

When was Access anti-HBc Total cleared by the FDA?

Access anti-HBc Total (K253687) received a 510(k) decision of Substantially Equivalent on February 19, 2026, 90 days after the submission was received.

What is the product code of K253687?

The FDA product code is SEI – Qualitative And Quantitative Hepatitis B Virus Antibody Assays, a Class II (moderate risk) device regulated under 21 CFR 866.3173.